STERIS plc (STE)
Last Price$222.71.6%
Market Cap$21.9B
STE Rating
STE Quality rating performance
STE Intrinsic Value
Key Highlights:
As of Mar 03, 2025 STE Relative Value is $291.9, which is undervalued by 31.1%, compared to current share price of $222.7.
As of Mar 03, 2025 STE DCF Value is $105.0, which is overvalued by 52.8%, compared to current share price of $222.7.
STE Share Price History
1W (0.4%)
1M 2.0%
6M (7.9%)
YTD 3.6%
1Y (3.8%)
3Y (6.3%)
5Y 44.4%
10Y 291.7%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
STE Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$21.9B
$21.9B
$5,398.4M
$751.4M
Shares Outstanding
98M
Employees
N/A
Growth (CAGR)
12.6%
12.9%
0.37%
17.2%
138.49%
Profitability
44.7%
17.7%
21.2%
13.9%
120.6%
Intrinsic Value
$199.6 (10.4% overvalued)
$107.0
$292.3
$299.4
$591.0
39.4%
Return on Capital
Financial Health
($30.2M)
(0.0x)
9.1x
Dividends
9.9%
1.0%
28.6%
Nov 19, 2024
Earnings
May 06, 2025
MISS by (0.1%)
BEAT by 0.9%
(8.2%)
6 Beat & 4 Miss
STE Stock Financials
STE Income Statement Metrics
Annual
Quarterly
LTM
STE Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$973.3M +28.6% YoY
Capital Expenditure (CAPEX)
($360.3M) -0.5% YoY
Free Cash Flow (FCF)
$612.9M +55.2% YoY
STE Income Statement Overview
Annual
Quarterly
LTM
Mar'15
Mar'16
Mar'17
Mar'18
Mar'19
Mar'20
Mar'21
Mar'22
Mar'23
Mar'24
$5,138.7M 3.6% YoY
Cost of revenue
$2,920.5M 4.4% YoY
Pre-tax income
$702.8M 346.7% YoY
13.7% margin
STE Balance Sheet Overview
Annual
Quarterly
LTM
Mar'15
Mar'16
Mar'17
Mar'18
Mar'19
Mar'20
Mar'21
Mar'22
Mar'23
Mar'24
Assets
Liabilities
Total assets
$11.1B
Current assets ($2,869.1M, 25.9% of total)
$207.0M (1.9%)
$1,008.3M (9.1%)
Other current assets
$1,653.8M (14.9%)
Non-current assets ($8,194.6M, 74.1% of total)
$0.0 (0.0%)
$1,938.4M (17.5%)
$2,119.3M (19.2%)
Other non-current assets
$4,136.9M (37.4%)
Financial position
$3,176.1M
Cash & Short-term
Investments
Total Debt
STE Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
STE Earnings Surprises
Crunching data... Almost there!
STE Dividends
STE Dividend Yield
Crunching data... Almost there!
STE Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with STE
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$21.9B | 6.2 | $199.6 10.4% overvalued | (3.8%) | $5,398.4M | $751.4M | (0.2%) | 13.9% | 44.7% | 8.2% | 1.9% | |
$242.4B | 7.0 | $174.5 24.5% undervalued | 19.2% | $42.0B | $6,351.0M | 4.6% | 15.1% | 55.6% | 25.3% | 31.4% | |
$154.5B | 6.7 | $34.2 67.4% overvalued | 55.5% | $16.7B | $2,438.0M | 17.6% | 14.6% | 67.0% | 8.0% | 50.7% | |
$150.5B | 6.6 | $305.1 22.7% overvalued | 12.0% | $22.6B | $3,487.0M | 10.2% | 15.4% | 62.8% | 14.6% | 28.4% | |
$120.9B | 6.2 | $114.6 21.5% undervalued | 14.7% | $33.2B | $5,467.0M | 2.7% | 16.5% | 52.7% | 7.4% | 53.6% | |
$43.4B | 6.1 | $54.1 24.2% overvalued | (18.0%) | $5,872.6M | $502.2M | 0.9% | 8.6% | 77.8% | 25.8% | 7.4% | |
$34.9B | 7.0 | $43.1 49.8% overvalued | (29.7%) | $4,033.0M | $453.9M | 11.3% | 11.3% | 60.4% | 21.7% | 120.3% | |
$24.7B | 5.3 | $65.0 146.8% undervalued | 34.0% | €18.0B | €274.0M | (0.8%) | 1.5% | 43.1% | (4.2%) | 63.4% | |
$21.6B | 5.9 | $181.2 72.0% undervalued | (15.3%) | $5,655.4M | $1,132.4M | (23.5%) | 20.0% | 64.3% | 4.5% | 43.0% | |
$19.4B | 7.9 | $134.5 50.7% overvalued | 62.5% | $1,900.3M | $303.0M | 12.0% | 15.9% | 76.4% | 29.7% | 6.9% | |
$13.6B | 6.0 | $190.0 8.5% undervalued | (43.2%) | $3,999.0M | $622.7M | 3.5% | 15.6% | 70.3% | 14.2% | 2.3% |
FAQ
What is STERIS plc (STE) stock rating?
As of today, STERIS plc has a stock rating of 6 (out of 10), which is considered Good.
is STERIS plc (STE) a good stock to buy?
As of today, STERIS plc has a Good stock rating, which is 10.4% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.